This is not the most recent version of the article. View current version (2 APR 2014)

Intervention Protocol

Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis

  1. Reshma Amin1,*,
  2. Valerie Waters2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 6 JUL 2011

Assessed as up-to-date: 13 JUN 2011

DOI: 10.1002/14651858.CD009249


How to Cite

Amin R, Waters V. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009249. DOI: 10.1002/14651858.CD009249.

Author Information

  1. 1

    The Hospital for Sick Children, Department of Pediatric Respirology, Toronto, Ontario, Canada

  2. 2

    Hospital for Sick Children, Department of Pediatrics, Division of Infectious Diseases, Toronto, Ontario, Canada

*Reshma Amin, Department of Pediatric Respirology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. reshma.amin@sickkids.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUL 2011

SEARCH

This is not the most recent version of the article. View current version (02 APR 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of our review is to assess the effectiveness of antibiotic treatment for S. maltophilia in people with CF. The primary objective is to assess this in relation to lung function and pulmonary exacerbations in the setting of acute pulmonary exacerbations and suppressive antibiotic therapy. The secondary objective is to assess this in relation to the eradication of S. maltophilia.